Effect of immunoglobulin variable region structure on C3b and C4b deposition

Molecular Immunology

Volumn 33, Issue 9, 1996, Pages 759-768

  White, Kendra D ^a   Frank, Mark Barton ^b   Foundling, Stephen ^b   Waxman, Frank J ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Antibody; Complement; Immune complex

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; MONOCLONAL ANTIBODY;

ANTIBODY AFFINITY; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN VARIABLE REGION; ISOELECTRIC POINT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030174530     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(96)00031-4     Document Type: Article

References (35)

1. Anton L. C., Alcolea J. M., Sanchez-Corral P., Maeques G., Sanchez A. and Vivanco F. (1989) C3 binds covalently to the CH3 domain of IgG immune aggregates during complement activation by the alternative pathway. Biochem. J. 257, 831-838.
2. Brown E. J., Berger M., Joiner K. A. and Frank M. M. (1983) Classical complement pathway activation by anti-pneumococcal antibodies leads to covalent binding of C3b to antibody molecules. Infect. Immun. 42(2), 594-598.
3. Campbell R. D., Dodds A. W. and Porter R. R. (1980) The binding of human complement component C4 to antibody-antigen aggregates. Biochem. J. 189, 67-80.
4. Carroll W. L., Mendel E. and Levy S. (1988) Hybridoma fusion cell lines contain an aberrant kappa transcript. Molec. Immun. 25(10), 991-995.
5. Co M. S., Avdalovic N. M., Caron P. C., Avdalovic M. V., Scheinberg D. A. and Queen C. (1992) Chimeric and humanized antibodies with specificity for the CD33 antigen. J. Immun. 148(4), 1149-1154.
6. Ey P. L., Prowse S. J. and Jenkin C. R. (1979) Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature 281, 492-493.
7. Ey P. L., Russell-Jones G. J. and Jenkin C. R. (1980) Isotypes of mouse IgG-1. Evidence for non-complement fixing IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Molec. Immun. 17, 699-710.
8. Fauci A. S., Frank M. M. and Johnson J. S. (1970) The relationship between antibody affinity and the efficiency of complement activation. J. Immun. 105(1), 215-220
9. Finzel B. C. (1993) Program "LORE", version 2.2. Physical and Analytical Chemistry, Upjohn Laboratories, Kalamazoo, MI.
10. Finzel B. C., Kimatian S., Ohlendorf D. H., Wendoloski J. J., Levitt M. and Salemme F. R. (1990) Molecular modeling with substructure libraries derived from known protein structures. In Crystallographic and Modeling Methods in Molecular Design (Edited by Bugg C. E. and Ealick S. E.), pp. 175-188. Springer-Verlag, New York. .
11. Gadd K. J. and Reid K. B. M. (1981) The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem. J. 195, 471-480.
12. Hebert L. A., Cosio F. G. and Neff J. C. (1991) Diagnostic significance of hypocomplementemia. Kidney Int. 39(5), 811-821
13. Hendrickson W. A. (1981) Refinement of Protein Structures (Edited by Machin P. A., Campbell J. W. and Elder M.), pp. 1-29. Daresbury Laboratory, U.K. .
14. Hendrickson W. A. (1985) Stereochemical constrained least squares refinement of protein models. Meth. Enzymol. 115, 252.
15. Herron J. N., He X. M., Mason M. L., Voss E. W., Jr. and Edmundson A. B. (1989) Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol. Proteins: Struc. Funct. Genet. 5, 271-280.
16. Hirayama N., Hirano T., Kohler G., Kurata A. kumu, Okumura K. and Ovary Z. (1982) Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. Proc. natn. Acad. Sci. U.S.A. 79, 613-615.
17. Horgan C., Brown K. and Pincus S. H. (1990) Alteration in H chain V region affects complement activation by chimeric antibodies. J. Immun. 145, 2527-2532.
18. Horgan C., Brown K. and Pincus S. H. (1992) Effect of H chain V region on complement activation by immobilized immune complexes. J. Immun. 149, 127-135
19. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S. and Foeller C. (1991) Sequences of Proteins of Immunological Interest. National Institutes of Health Publication No. 91-3242, Bethesda, MD.
20. Kulics J., Rajnavolgyi E., Fust G. and Gergely J. (1983) Interaction of C3 and C3b with immunoglobulin G. Molec. Immun. 20, 805-810.
21. Lascombe M. B., Alzari P. M., Poljak R. J. and Nisonoff A. (1992) Three-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibody. Proc. natn. Acad. Sci. U.S.A. 89, 9429-9433.
22. Lee B. and Richards F. M. (1971) The interpretation of protein structures: Estimation of static accessibility. J. molec. Biol. 55, 379-400.
23. Neuberger M. S. and Rajewsky K. (1981) Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immun. 11, 1012-1016.
24. Padlan E. A., Silverton E. W., Sheriff S., Cohen G. H., Smith-Gill S. J. and Davies D. R. (1989) Structure of an antibody-antigen complex:crystal structure of the HyHEL-10 Fablysozyme complex. Proc. natn. Acad. Sci. U.S.A. 86, 5938-5942.
25. Rath S., Stanley C. M. and Steward M. W. (1988) An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J. immunol. Meth. 106, 245-249.
26. Riley S. C., Connors S. J., Klinman N. R. and Ogata R. T. (1986) Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes. Proc. natn. Acad. Sci. U.S.A. 83, 2589-2593
27. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. .
28. Shohet J. M., Pemberton P. and Carroll M. C. (1993) Identification of a major binding site for complement c3 on the IgG1 heavy chain. J. biol. Chem. 268(8), 5866-5871.
29. Sim R. B., Twose T. M., Paterson D. S. and Sim E. (1981) The covalent-binding reaction of complement component C3. Biochem. J. 193, 115-127.
30. Steward M. W. and Lew A. M. (1985) The importance of antibody affinity in the performance of immunoassays for antibody. Immunol. Meth. 78, 173-190.
31. Stewart W. W., Johnson A., Steward M. W., Whaley K. and Kerr M. A. (1990) The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: Correlation with the prevention of immune precipitation. Molec. Immun. 27, 423-428.
32. Takata Y., Tamura N. and Fujita T. (1984) Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune complexes. J. Immun. 132, 2531-2537.
33. Yokoyama I. and Waxman F. (1992) Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor. Molec. Immun. 29, 935-947.
34. Yokoyama I. and Waxman F. (1993) Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes. Immunology 80, 168-176.
35. Yokoyama I. and Waxman F. (1994) Differential susceptibility of immune complexes to release from the erythrocyte CR1 receptor by Factor I. Molec. Immun. 31, 227-240.